CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at an average $33.93 ($305,385)
- 4 Planned sale Director sold 61,200 shares at an average $34.57 ($2,115,673)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 5,000 shares at $30.00 ($150,005)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $28.00 ($112,000)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 3,748 shares at $30.00 ($112,447)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $29.30 ($117,200)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $30.38 ($273,442)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $31.53 ($283,776)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 895 shares (to pay taxes)
- 4 Planned sale SVP, Chief Commercial Officer sold 6,667 shares at an average $31.52 ($210,143)
- 4 Shares withheld for taxes Director gave up 793 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,924 shares (to pay taxes)
Page 4 of 67 · 1,323 filings